Mayo Clinic-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2022

  1. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

    Annals of Oncology, Vol. 33, Núm. 11, pp. 1119-1133

2018

  1. CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v84

2017

  1. Clinicopathological factors influence diagnostic accuracy of clinical N staging for early gastric cancer

    Annals of Oncology, Vol. 28, pp. iii135-iii136

2016

  1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Annals of Oncology, Vol. 27, Núm. 8, pp. 1386-1422

2011

  1. The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

    Annals of Oncology

2003

  1. Gastric cancer: Epidemiology, pathology and treatment

    Annals of Oncology, Vol. 14, Núm. SUPPL. 2